Next Nanotechnology

OCT 14, 2026 · JOURNAL ARTICLE

Temperature and pH responsive smart nano carriers for drug delivery: Synthesis strategies, mechanism of action and biomedical applications-an updated review

Next Nanotechnology

Stimuli responsive nanocarriers provide enhanced versatility and functionality in biomedical applications because they are made to respond to various types of internal stimuli such

OCT 6, 2026 · JOURNAL ARTICLE

Nanomaterial-assisted epigenetic engineering of the blood–brain barrier: A dual strategy for drug delivery and permeability control

Next Nanotechnology

Recent advances at the interface of nanotechnology, epigenetics, and neurobiology have created new opportunities to address the blood–brain barrier (BBB), a major challenge in the

OCT 4, 2026 · JOURNAL ARTICLE

Mesoporous fluoridated hydroxyapatite nanorods as a multifunctional platform for potential cancer-induced bone defect repair

Next Nanotechnology

Objective For cancer-induced bone defects, cancer therapy is as important as tissue repair. Therefore, multifunctional materials with both anticancer and regenerative properties ar

SEP 22, 2026 · JOURNAL ARTICLE

Leveraging exosomes and lipid nanoparticles based nanomedicine for cervical cancer therapeutics

Next Nanotechnology

Cervical cancer (CC) remains a significant global health burden, ranking as the fourth most common cancer among women worldwide. Persistent infection with high-risk human papilloma

SEP 22, 2026 · JOURNAL ARTICLE

Black phosphorus quantum dots for precision oncology: From design to translation

Next Nanotechnology

Black phosphorus quantum dots (BPQDs) have emerged as a promising class of biodegradable nanomaterials for precision oncology owing to their unique physicochemical properties, quan

SEP 8, 2026 · JOURNAL ARTICLE

Mesoporous silica nanoparticles as an advanced tool for cancer therapy

Next Nanotechnology

This is a narrative review assessing MSN technology for cancer therapy without reporting original clinical trial data, efficacy comparisons, or quantified outcomes; it raises mechanistic and design questions rather than answering them with empirical evidence.

SEP 3, 2026 · JOURNAL ARTICLE

The inspiration of CRISPR-Cas: Interface of nature with a pharmacy: A compatible horizon of cancer treatment

Next Nanotechnology

This is a narrative review discussing CRISPR-Cas potential in oncology without reporting empirical data, clinical outcomes, or trial results; it presents conceptual possibilities and technical developments rather than evidence of efficacy.

AUG 25, 2026 · JOURNAL ARTICLE

Plant-derived exosome-like nanoparticles from traditional Chinese medicine herbs: A nanobiological framework for antimicrobial phytochemical delivery

Next Nanotechnology

This is a narrative review synthesizing preclinical mechanistic evidence and proposing a theoretical framework; it does not report primary experimental data, clinical outcomes, or comparative efficacy studies.